Company / Assets per Share
Denali Therapeutics Inc. Assets per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$7.94
FY2025
5-year range
$7.94 / $11.94
FY2021-FY2025
Trend
-20.1%
vs FY2024
Sector context
#116 of 210
Health Care
What the data says
At $7.94, Denali Therapeutics Inc.'s assets per share ranks #116 of 210 in the Health Care sector. Assets per Share has fluctuated over the past 9 years, ranging from $5.84 in FY2019 to $32.53 in FY2017.
Based on SEC 10-K filings.
7.94 in FY2025 with a 5-year CAGR of -13.8%.
Declined from $8.49 to $7.94 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -12.7%
- 5-Year CAGR
- -13.8%
- 10-Year CAGR
- -
Sector benchmark
#116 of 210 in Health CareTop 55% of 210This company $7.94 Sector average $296.79
▼
-97.3% below sector average
Key checks
Key Insights
- In FY2025, assets per share decreased 20.1% year-over-year.
- Ranks #116 out of 210 companies in the Health Care sector.
- Peak assets per share was recorded in FY2017.
- Lowest assets per share in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.73 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.94 | -20.1% |
| FY2024 | $9.93 | +17.0% |
| FY2023 | $8.49 | -28.9% |
| FY2022 | $11.94 | +2.5% |
| FY2021 | $11.65 | -30.1% |
| FY2020 | $16.68 | +185.4% |
| FY2019 | $5.84 | -22.8% |
| FY2018 | $7.57 | -76.7% |
| FY2017 | $32.53 | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026